MEDTRONIC SINGAPORE OPERATIONS
Manufacturer adverse-event records for MEDTRONIC SINGAPORE OPERATIONS come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2011–2026 · heavy-book · elevated Death-code · balanced
Volume signature
MEDTRONIC SINGAPORE OPERATIONS sits in the heavy MAUDE book
MEDTRONIC SINGAPORE OPERATIONS accounts for 54,416 FDA MAUDE reports (#64 of 443, heavy-book tercile). Death-coded event_type share is 1.51% (elevated); Injury share 36.8% (balanced).
What the volume reading shows for MEDTRONIC SINGAPORE OPERATIONS
The standout signal for MEDTRONIC SINGAPORE OPERATIONS is filing volume: 54,416 adverse-event reports in FDA MAUDE (#64 of 443, heavy-book). Death-coded event_type share sits at 1.51% (elevated).
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair MEDTRONIC SINGAPORE OPERATIONS with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 13 device types, led in this extract by Malfunction at 33,595 (61.7% of event_type total). Peak single-year volume reaches 9,820 reports across 16 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (13)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.